{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T10:27:09Z","timestamp":1744799229035},"reference-count":29,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.3892\/etm.2017.4791","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T08:58:51Z","timestamp":1499849931000},"page":"1993-1998","source":"Crossref","is-referenced-by-count":5,"title":["Application of urine cells in drug intervention for spinal muscular atrophy"],"prefix":"10.3892","volume":"14","author":[{"given":"Qi-Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Qian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"En-Lin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,7,12]]},"reference":[{"key":"key20180108135251_b1-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: A timely review","volume":"68","author":"Kolb","year":"2011","journal-title":"Arch Neurol"},{"key":"key20180108135251_b2-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ejhg.2010.54","article-title":"Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population","volume":"18","author":"Sheng-Yuan","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"key20180108135251_b3-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"key20180108135251_b4-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10048-010-0268-z","article-title":"Hydroxyurea enhances SMN2 gene expression through nitric oxide release","volume":"12","author":"Xu","year":"2011","journal-title":"Neurogenetics"},{"key":"key20180108135251_b5-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.expneurol.2011.01.017","article-title":"Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms","volume":"229","author":"Nizzardo","year":"2011","journal-title":"Exp Neurol"},{"key":"key20180108135251_b6-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"key20180108135251_b7-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","article-title":"Valproate may improve strength and function in patients with type III\/IV spinal muscle atrophy","volume":"67","author":"Weihl","year":"2006","journal-title":"Neurology"},{"key":"key20180108135251_b8-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"e12140","DOI":"10.1371\/journal.pone.0012140","article-title":"SMA CARNI-VAL trial part I: Double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy","volume":"5","author":"Swoboda","year":"2010","journal-title":"PLoS One"},{"key":"key20180108135251_b9-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"e21296","DOI":"10.1371\/journal.pone.0021296","article-title":"SMA CARNIVAL TRIAL PART II: A prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy","volume":"6","author":"Kissel","year":"2011","journal-title":"PLoS One"},{"key":"key20180108135251_b10-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2377-11-36","article-title":"Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid","volume":"11","author":"Darbar","year":"2011","journal-title":"BMC Neurol"},{"key":"key20180108135251_b11-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/mus.23904","article-title":"SMA valiant trial: A prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy","volume":"49","author":"Kissel","year":"2014","journal-title":"Muscel Nerve"},{"key":"key20180108135251_b12-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/WNR.0b013e32835e2e44","article-title":"Noninvasive urine-derived cell lines derived from neurological genetic patients","volume":"24","author":"Zhang","year":"2013","journal-title":"Neuroreport"},{"key":"key20180108135251_b13-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-2001-15264","article-title":"Spinal muscular atrophy","volume":"21","author":"Talbot","year":"2001","journal-title":"Semin Neurol"},{"key":"key20180108135251_b14-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.braindev.2011.04.010","article-title":"Valproic acid increases SMN2 expression and modulates SF2\/ASF and hnRNPA1 expression in SMA fibroblast cell lines","volume":"34","author":"Harahap","year":"2012","journal-title":"Brain Dev"},{"key":"key20180108135251_b15-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-4159.2006.03868.x","article-title":"In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy","volume":"98","author":"Hahnen","year":"2006","journal-title":"J Neurochem"},{"key":"key20180108135251_b16-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"Porensky","year":"2012","journal-title":"Hum Mol Genet"},{"key":"key20180108135251_b17-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/01.wnl.0000201929.56928.13","article-title":"SMN mRNA and protein levels in peripheral blood: Biomarkers for SMA clinical trials","volume":"66","author":"Sumner","year":"2006","journal-title":"Neurology"},{"key":"key20180108135251_b18-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ana.22487","article-title":"Stem cell technology for neurodegenerative diseases","volume":"70","author":"Lunn","year":"2011","journal-title":"Ann Neurol"},{"key":"key20180108135251_b19-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann Neurol"},{"key":"key20180108135251_b20-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice","volume":"86","author":"Tsai","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"key20180108135251_b21-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"key":"key20180108135251_b22-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum Mol Genet"},{"key":"key20180108135251_b23-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/hmg\/ddq023","article-title":"SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy","volume":"19","author":"Riessland","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key20180108135251_b24-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neulet.2013.03.052","article-title":"Increasing SMN levels using the histone deacetylase inhibitor SAHA ameliorates defects in skeletal muscle microvasculature in a mouse model of severe spinal muscular atrophy","volume":"544","author":"Somers","year":"2013","journal-title":"Neurosci Lett"},{"key":"key20180108135251_b25-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4161\/rna.7.4.12206","article-title":"Repair of pre-mRNA splicing: Prospects for a therapy for spinal muscular atrophy","volume":"7","author":"Nlend","year":"2010","journal-title":"RNA Biol"},{"key":"key20180108135251_b26-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/mt.2013.276","article-title":"Dual masking of specific negative splicing regulatory elements resulted in maximal exon 7 inclusion of SMN2 gene","volume":"22","author":"Pao","year":"2014","journal-title":"Mol Ther"},{"key":"key20180108135251_b27-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"key20180108135251_b28-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clinthera.2014.02.004","article-title":"Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy \u03947 mouse model phenotype","volume":"36","author":"Nizzardo","year":"2014","journal-title":"Clin Ther"},{"key":"key20180108135251_b29-etm-0-0-4791","doi-asserted-by":"crossref","first-page":"E5863","DOI":"10.1073\/pnas.1509758112","article-title":"Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II\/III spinal muscular atrophy","volume":"112","author":"Bogdanik","year":"2015","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:21:53Z","timestamp":1515457313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.4791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,12]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,7,12]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.3892\/etm.2017.4791"],"URL":"https:\/\/doi.org\/10.3892\/etm.2017.4791","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,12]]}}}